Cargando…
Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
Genetic variations in individuals may cause differences in the response to cholinesterase inhibitor drugs used in the treatment of Alzheimer’s disease (AD). Through this review, we aimed to understand the potential relationship between genetic polymorphisms and treatment response in AD. We conducted...
Autores principales: | Sumirtanurdin, Riyadi, Thalib, Amirah Y, Cantona, Kelvin, Abdulah, Rizky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445219/ https://www.ncbi.nlm.nih.gov/pubmed/30992661 http://dx.doi.org/10.2147/CIA.S200109 |
Ejemplares similares
-
Polymorphism of TPH2 Gene rs120074175 Is Not Associated with Risk Factors of Schizophrenia
por: Laksono, James P., et al.
Publicado: (2019) -
Single-nucleotide Polymorphism of CTLA-4 (rs5742909) in Correlation with Schizophrenia Risk Factor
por: Sumirtanurdin, Riyadi, et al.
Publicado: (2019) -
Type 2 Diabetes-Associated Genetic Polymorphisms as Potential Disease Predictors
por: Witka, Beska Z, et al.
Publicado: (2019) -
Genetic Polymorphisms and the Clinical Response to Systemic Lupus Erythematosus Treatment Towards Personalized Medicine
por: Barliana, Melisa Intan, et al.
Publicado: (2022) -
Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review
por: Afifah, Nadiya Nurul, et al.
Publicado: (2020)